CVS Pharmacy agreed to pay $18.2 million to settle allegations it submitted false claims to California’s Medi-Cal program between 2010 and 2021, resolving a case brought under the state’s False Claims Act.
- US will receive 44.34% of the settlement proceeds
- CVS knowingly failed to verify or document mandatory compliance for a large number of claims, resulting in the payment of millions of dollars of false claims by Medi-Cal
To view the source of this information click
To contact the reporter on this story:
To contact the editor responsible for this story:
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.